GCG/GLP-1 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

62,218 results for “GCG/GLP-1”

Trials

View all 37530 →

GIP and GLP-1 in Type 1 Diabetes

10 participants · First posted Dec 3, 2012

Discontinuation One Week Recommendations for GLP-1 Receptor Agonists Prior to Esophagogastroduodenoscopy.

140 participants · First posted Jul 30, 2026

Discontinuation Recommendations for GLP-1 Receptor Agonists Prior to Colonoscopy

240 participants · First posted Jul 30, 2026

Drugs

View all 7817 →

rHSA-GLP-1

GLP-1 derivative

APB-GLP-1

Organizations

View all 1455 →

NHI-1

United States

Xi'an No.1 Hospital

China

ALPHA-1 FOUNDATION, INC.

United States

News

View all 15416 →

China's Mazdutide Achieves Breakthrough as World's First GCG/GLP-1 Dual Receptor Agonist for Weight Loss

Innovent to Present Phase 3 Results of Dual GLP-1/Glucagon Receptor Agonist Mazdutide at ADA 2025

Innovent Initiates Head-to-Head Phase 3 Trial of Mazdutide vs Semaglutide for Obesity with Fatty Liver Disease

Page 1 of 6222